14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Kidney Failure, Chronic in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, HE | 1 |
| Jones, JP | 1 |
| Kalhorn, TF | 1 |
| Farin, FM | 1 |
| Stapleton, PL | 1 |
| Davis, CL | 1 |
| Perkins, JD | 1 |
| Blough, DK | 1 |
| Hebert, MF | 1 |
| Thummel, KE | 1 |
| Totah, RA | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.
Topics: 8,11,14-Eicosatrienoic Acid; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Calcineurin Inhibitors | 2008 |